Verition Fund Management »

BioCryst Pharmaceuticals shares owned by Verition Fund Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $409k 54k 7.52
2024-09-30 $300k 40k 7.60
2024-06-30 $880k 142k 6.18
2023-09-30 $347k 49k 7.08
2023-06-30 $216k 31k 7.04
2023-03-31 $186k 22k 8.34
2022-03-31 $252k 16k 16.24
2021-06-30 $231k 15k 15.79
2020-09-30 $1.9M 542k 3.43